Protein-carbohydrate interactions: Learning lessons from nature

Trends in Biotechnology

Volumn 19, Issue 9, 2001, Pages 356-362

  Williams, Spencer J ^a   Davies, Gideon J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOSYNTHESIS; CATALYSIS; DISEASES; ENZYMES; FUNGI; PATHOLOGY; TOXIC MATERIALS; TUMORS;

THERAPEUTICS;

CARBOHYDRATES;

1 DEOXYMANNONOJIRIMYCIN; ACARBOSE; ALPHA 1 ANTITRYPSIN; ANTICOAGULANT AGENT; ANTITHROMBIN III; BACTERIAL TOXIN; BLOOD CLOTTING FACTOR 10A; CELL SURFACE RECEPTOR; GALACTOSYLTRANSFERASE; GLUCOSYLTRANSFERASE; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSYLTRANSFERASE; HEPARIN; IMIDAZOLE; KIFUNENSINE; LOW MOLECULAR WEIGHT HEPARIN; MANNOSIDASE; MIGLITOL; OLIGOSACCHARIDE; OSELTAMIVIR; THROMBIN; VEROTOXIN; XYLAN ENDO 1,3 BETA XYLOSIDASE; ZANAMIVIR;

BIOTECHNOLOGY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BINDING SITE; BLOOD CLOTTING; CANCER; CARBOHYDRATE SYNTHESIS; CARDIOVASCULAR DISEASE; CATALYSIS; CROSS REACTION; CRYSTAL STRUCTURE; ENZYME BINDING; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYDROLYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTON TRANSPORT; REVIEW; X RAY CRYSTALLOGRAPHY;

CARBOHYDRATE METABOLISM; CARBOHYDRATE SEQUENCE; CARBOHYDRATES; GLYCOSIDE HYDROLASES; GLYCOSYLTRANSFERASES; HEPARIN; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEINS; SHIGA TOXIN;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 0035451542     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(01)01699-7     Document Type: Review

References (38)

1. Intervention of carbohydrate recognition by proteins and nucleic acids
2. Chemistry and biochemistry of microbial α-glucosidase inhibitors
3. Rational design of potent sialidase-based inhibitors of influenza virus replication
4. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
5. Structural basis for catalysis and inhibition of N-glycan processing class I α-1,2-mannosidases
6. Crystal structure of a class I α-1,2-mannosidase involved in N-glycan processing and endoplasmic reticulum quality control
7. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome
8. Recent insights into inhibition, structure and mechanism of configuration retaining glycosidases
9. Structures and mechanisms of glycosyl hydrolases
10. Lateral protonation of a glycosidase inhibitor. Structure of the Bacillus agaradhaerens Cel5A in complex with a cellobiose-derived imidazole at 0.97 Å resolution
11. Nanomolar versus millimolar inhibition by xylobiose-derived azasugars: Significant differences between two structurally distinct xylanases
12. Detailed structural analysis of glycosidase/inhibitor interactions: Complexes of Cex from Cellulomonas fimi with xylobiose-derived aza-sugars
13. Glycosyltransferase structure and mechanism
14. Crystal structure of the DNA modifying enzyme β-glucosyltransferase in the absence of the substrate uridine diphosphoglucose
15. Crystal structures of the bovine β4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose
16. Structure of the nucleotide-diphospho-sugar transferase, SpsA from Bacillus subtilis, in native and nucleotide-complexed forms
17. X-ray crystal structure of rabbit N-acetylglucosaminyltransferase I: Catalytic mechanism and a new protein superfamily
18. The 1.9 Å crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis
19. Heparan/Chondroitin sulfate biosynthesis
20. Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs
21. Sweet secrets of synthesis
22. The anticoagulant activation of antithrombin by heparin
23. The unique antithrombin III binding domain of heparin: A lead to new synthetic antithrombotics
24. Synthesis of thrombin-inhibiting heparin mimetics without side effects
25. Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)
26. Mode of interaction between platelet factor 4 and heparin
27. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity
28. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to Chromosorb for preventing hemolytic-uremic syndrome
29. 3
30. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design
31. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
32. Mechanisms of enzymatic glycoside hydrolysis
33. Glycosidase mechanisms: Anatomy of a finely tuned catalyst
34. Glycosidase mechanisms
35. Structural and sequence-based classification of glycoside hydrolases
36. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
37. Raster3D: Photorealistic molecular graphics